Target Prioritization Review

Bring one active program.
We’ll examine it together.

In this 30-minute working session, our team reviews the candidate targets being considered within your disease context, examining the biological, genetic, and molecular evidence supporting each.

You leave with a clearer decision and defined next steps.

In this session we will:

Review the disease biology criteria for target success
Examine the evidence supporting each candidate target
Identify where targets show consistent biological support
Determine which targets merit deeper investment

Please fill in the details to get started.

Start your review